Canntab Therapeutics Limited is a Canada-based phytopharmaceutical company. The Company is focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. Its hard pill cannabinoid formulations provide doctors, patients and consumers with medical grade solutions. The Company’s operations comprise a single segment engaged in the medical marijuana business. Its products include INSTANT RELEASE - (IR Tablet), EXTENDED-RELEASE - (XR Tablet), and ORAL DISSOLVING - O.D. Tablet. It holds a cannabis standard processing and sales for medical purposes license and a cannabis research license from health Canada.